InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol

Fulvio Braido, Guy Brusselle, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth, LIAISON study group, Wolfgang Pohl, Guy Joos, Markus Hoefer, Serge Verdier, Judit Schlezák, Giorgio Walter Canonica, Jan Van Den Berge, Marek Michnar, Vicente Plaza, Nihal Arzu Mirici, Jaykumar Purohit, Fulvio Braido, Guy Brusselle, Eleonora Ingrassia, Gabriele Nicolini, David Price, Nicolas Roche, Joan B Soriano, Heinrich Worth, LIAISON study group, Wolfgang Pohl, Guy Joos, Markus Hoefer, Serge Verdier, Judit Schlezák, Giorgio Walter Canonica, Jan Van Den Berge, Marek Michnar, Vicente Plaza, Nihal Arzu Mirici, Jaykumar Purohit

Abstract

Background: According to international guidelines, the goal of asthma management is to achieve and maintain control of the disease, which can be assessed using composite measures. Prospective studies are required to determine how these measures are associated with asthma outcomes and/or future risk. The 'InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol (LIAISON)' observational study has been designed to evaluate asthma control and its determinants, including components of asthma management.

Methods/design: The LIAISON study will be conducted in 12 European countries and comprises a cross-sectional phase and a 12-month prospective phase. Both phases will aim at assessing asthma control (six-item Asthma Control Questionnaire, ACQ), asthma-related quality of life (Mini Asthma Quality of Life Questionnaire, Mini-AQLQ), risk of non-adherence to treatment (four-item Morisky Medication Adherence Scale, MMAS-4), potential reasons for poor control, treatment strategies and associated healthcare costs.The cross-sectional phase will recruit > 8,000 adult patients diagnosed with asthma for at least 6 months and receiving the same asthma treatment in the 4 weeks before enrolment.The prospective phase will include all patients with uncontrolled/poorly controlled asthma at the initial visit to assess the proportion reaching control during follow-up and to examine predictors of future risk. Visits will take place after 3, 6 and 12 months.

Discussion: The LIAISON study will provide important information on the prevalence of asthma control and on the quality of life in a broad spectrum of real-life patient populations from different European countries and will also contribute to evaluate differences in management strategies and their impact on healthcare costs over 12 months of observation.

Trial registration: ClinicalTrials.gov identifier, NCT01567280.

Figures

Figure 1
Figure 1
Study design.

References

    1. GINA report, global strategy for asthma management and prevention. 2012. 2011 Accessed September.
    1. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, Aït Khaled N, Baena-Cagnani CE, Barreto ML, Billo N, Canonica GW, Carlsen KH, Chavannes N, Chuchalin A, Drazen J, Fabbri LM, Gerbase MW, Humbert M, Joos G, Masjedi MR, Makino S, Rabe K, To T, Zhi L. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J. 2010;36(5):995–1001. doi: 10.1183/09031936.00012610.
    1. Accordini S, Corsico AG, Braggion M, Gerbase MW, Gislason D, Gulsvik A, Heinrich J, Janson C, Jarvis D, Jõgi R, Pin I, Schoefer Y, Bugiani M, Cazzoletti L, Cerveri I, Marcon A, de Marco R. The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2012;160(1):93–101.
    1. Levy ML. Guideline-defined asthma control: a challenge for primary care. Eur Respir J. 2008;31:229–231. doi: 10.1183/09031936.00157507.
    1. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The gaining optimal asthma controL study. Am J Respir Crit Care Med. 2004;170:836–844. doi: 10.1164/rccm.200401-033OC.
    1. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114(1):40–47. doi: 10.1016/j.jaci.2004.04.042.
    1. Stanford RH, Gilsenan AW, Ziemiecki R, Zhou X, Lincourt WR, Ortega H. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS) J Asthma. 2010;47(3):257–262. doi: 10.3109/02770900903584019.
    1. Liu AH, Gilsenan AW, Stanford RH, Lincourt W, Ziemiecki R, Ortega H. Status of asthma control in pediatric primary care: results from the pediatric Asthma Control Characteristics and Prevalence Survey Study (ACCESS) J Pediatr. 2010;157(2):276–281. doi: 10.1016/j.jpeds.2010.02.017.
    1. Mintz M, Gilsenan AW, Bui CL, Ziemiecki R, Stanford RH, Lincourt W, Ortega H. Assessment of asthma control in primary care. Curr Med Res Opin. 2009;25(10):2523–2531. doi: 10.1185/03007990903218655.
    1. Mehuys E, Van Bortel L, Annemans L, Remon JP, Van Tongelen I, Van Ganse E, Laforest L, Chamba G, Brusselle G. Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study. Respir Med. 2006;100(8):1407–1414. doi: 10.1016/j.rmed.2005.11.013.
    1. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13. doi: 10.1186/1471-2466-6-13.
    1. Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, Cerveri I, Duran-Tauleria E, Gislason D, Gulsvik A, Jõgi R, Marinoni A, Martínez-Moratalla J, Vermeire P, de Marco R. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120(6):1360–1367. doi: 10.1016/j.jaci.2007.09.019.
    1. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–907. doi: 10.1034/j.1399-3003.1999.14d29.x.
    1. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65. doi: 10.1016/j.jaci.2003.09.008.
    1. Van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, Assendelft WJ, Sterk PJ, Rabe KF, Sont JK. SMASHING (Self-Management of Asthma Supported by Hospitals, ICT, Nurses and General practitioners) Study Group. Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respiratory Research. 2010;11:74. doi: 10.1186/1465-9921-11-74.
    1. Demoly P, Paggiaro P, Plaza V, Bolge SC, Kannan H, Sohier B, Adamek L. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev. 2009;18(112):105–112. doi: 10.1183/09059180.00001209.
    1. Demoly P, Gueron B, Annunziata K, Adamek L, Walters RD. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev. 2010;19(116):150–157. doi: 10.1183/09059180.00002110.
    1. Allegra L, Cremonesi G, Girbino G, Ingrassia E, Marsico S, Nicolini G, Terzano C. PRISMA (PRospectIve Study on asthMA control) Study Group: Real-life prospective study on asthma control in Italy: cross-sectional phase results. Respir Med. 2012;106(2):205–214. doi: 10.1016/j.rmed.2011.10.001.
    1. Bettoncelli G, Magnoni MS, Fassari C, Tosatto R, Di Blasi P, De Marco R, Novelletto BF, Mazzaglia GP, Caramori G. Studio P.A.C.I.S. (Point out Asthma Control Italian Survey) Il controllo dell’asma in Italia misurato con ACT (Asthma Control Test) Società Italiana di Medicina Generale. 2006;6:10–17.
    1. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802–807. doi: 10.1183/09031936.00.16580200.
    1. De Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O, Carrozzi L, Dallari R, Giammanco G, Ginesu F, Marinoni A, Lo Cascio V, Poli A, Struzzo P, Janson C. ISAYA study group. The control of asthma in Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy. 2003;58(3):221–228. doi: 10.1034/j.1398-9995.2003.00059.x.
    1. Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, Versnel J, Shanahan ER, Hillyer EV, Tunsäter A, Bjermer L. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med. 2008;102(12):1681–1693. doi: 10.1016/j.rmed.2008.08.003.
    1. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J. 1999;14:32–38. doi: 10.1034/j.1399-3003.1999.14a08.x.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986;24:67–74. doi: 10.1097/00005650-198601000-00007.
    1. Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011;64(3):255–257. doi: 10.1016/j.jclinepi.2010.09.002. discussion 258–263.
    1. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O’Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. doi: 10.1164/rccm.200801-060ST.
    1. O’Byrne PM, Reddel HK, Eriksson G, Ostlund O, Peterson S, Sears MR, Jenkins C, Humbert M, Buhl R, Harrison TW, Quirce S, Bateman ED. Measuring asthma control: a comparison of three classification systems. Eur Respir J. 2010;36(2):269–276. doi: 10.1183/09031936.00124009.
    1. Ehrs PO, Nokela M, Ställberg B, Hjemdahl P, Jonsson EW. Brief Questionnaires for Patient-Reported Outcomes in Asthma Validation and Usefulness in a Primary Care Setting. Chest. 2006;129:925–932. doi: 10.1378/chest.129.4.925.
    1. McLeish AC, Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical literature. J Asthma. 2010;47(4):3452–3461.
    1. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124:474–481. doi: 10.1378/chest.124.2.474.
    1. Briggs AH, Bousquet J, Wallace MV, Busse WW, Clark TJ, Pedersen SE, Bateman ED. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy. 2006;61:531–536. doi: 10.1111/j.1398-9995.2006.01038.x.
    1. Williams SA, Wagner S, Kannan H, Bolge SC. The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med. 2009;51(7):780–785. doi: 10.1097/JOM.0b013e3181abb019.
    1. Honkoop PJ, Loymans RJ, Termeer EH, Snoeck-Stroband JB, Bakker MJ, Assendelft WJ, Sterk PJ, Ter Riet G, Schermer TR, Sont JK. Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment. BMC Pulm Med. 2011;11:53. doi: 10.1186/1471-2466-11-53.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner